Resurrect Bio
London, UK-based biotechnology company that supports the agriculture sector by equipping crops with genetic defenses against disease
Resurrect Bio has raised €16M across 2 funding rounds from 6 investors, most recently a Series A round in May 2026. Based in London, UK; active in Agritech. Data as of 28 Oct 2026.
London, UKwww.resurrect.bio ↗
Total raised
€16M
€15,683,658
Funding rounds
2
Investors
6
distinct backers
Active since
2026-02
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDResurrect Bio — funding by year — interactive chart.
Data table
| Resurrect Bio — funding by year | |
|---|---|
| 2026 | €16M |
Signals
High confidenceRaise-next likelihood35
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-15 | Series A | €8.8M | AgFunder,Calculus Capital,Corteva,Pymwymic,Synbioven,UKI2S | View deal → |
| 2026-02-20 | Series A | €6.9M | AgFunder,Calculus Capital,Corteva,Pymwymic,Synbioven,UKI2S | View deal → |